Press Release
Category Added in a WPeMatico Campaign
-
NetActuate Supports Raleigh-Durham-Chapel Hill Triangle with Investments in Technology Access and Education
RALEIGH, N.C., Oct. 13, 2025 /PRNewswire/ — NetActuate, a global provider of network and infrastructure services, is proud to reaffirm its…
Read More » -
Level Education Group Acquires Triad to Transform the Educational and Professional Pathway for Behavioral and Mental Health Professionals
SOUTH JORDAN, Utah, Oct. 13, 2025 /PRNewswire/ — Level Education Group, LLC (“LEG”), a leader in continuing education for mental…
Read More » -
Business Wire4 weeks ago
IonQ Quantum Computing Achieves Greater Accuracy Simulating Complex Chemical Systems to Potentially Slow Climate Change
New advancement lays groundwork for quantum-enhanced modeling in carbon capture and molecular dynamics COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), a…
Read More » -
Business Wire4 weeks ago
Daiichi Sankyo Continues to Transform Standards of Care for Patients with Three Landmark Breast Cancer Trials and Additional Data Across Industry-Leading ADC Portfolio at ESMO
Back-to-back Presidential Symposium presentations of ENHERTU from DESTINY-Breast11 and DESTINY-Breast05 demonstrate its potential to become a foundational treatment in curative-intent…
Read More » -
Business Wire4 weeks ago
Wellington Management Appoints Michael Trihy as Head of Portfolio Management to Expand Private Investment Capabilities into Evergreen Market
BOSTON & NEW YORK & LONDON–(BUSINESS WIRE)–Wellington Management (“Wellington”), one of the world’s largest independent investment management firms with over…
Read More » -
Business Wire4 weeks ago
Semtech Corporation Announces Full Exercise of Greenshoe Option and Closing of Private Offering
CAMARILLO, Calif.–(BUSINESS WIRE)–Semtech Corporation (Nasdaq: SMTC) (the “Company” or “Semtech”) today announced the closing of its offering of $350 million…
Read More » -
Business Wire4 weeks ago
AstraZeneca furthers ambition to redefine cancer care with first data from four major pivotal trials at ESMO
Presidential Symposium will feature DESTINY-Breast11 and DESTINY-Breast05, underscoring potential of ENHERTU® (fam-trastuzumab deruxtecan-nxki) in HER2-positive early breast cancer TROPION-Breast02 data…
Read More » -
Shield AI and Parry Labs Announce Strategic Collaboration to Deliver Integrated Autonomy at the Edge
WASHINGTON, Oct. 13, 2025 /PRNewswire/ — Shield AI and Parry Labs today announced a Memorandum of Understanding (MoU) to integrate…
Read More » -
StoryOne: Human-Centric AI Publishing launches ahead of Frankfurt Book Fair 2025
VIENNA, Oct. 13, 2025 /PRNewswire/ — Next Wednesday (October 15) marks the official start of the Frankfurt Book Fair –…
Read More » -
Vertiv Names Craig Chamberlin as Chief Financial Officer
COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ — Vertiv Holdings Co (NYSE: VRT), a global leader in critical digital infrastructure, today announced…
Read More »




